Literature DB >> 6331998

The relationship between glucose-6-phosphate dehydrogenase deficiency and cataracts in Sardinia. An epidemiological and biochemical study.

N Orzalesi, M Fossarello, R Sorcinelli, U Schlich.   

Abstract

The Italian island of Sardina occupies an important position on the map of glucose-6-phosphate dehydrogenase (G6PD)-deficiency distribution throughout the world, since in this region the condition is particularly frequent and severe (erythrocytes show only 0-7% of G6PD normal activity, while people result affect up to 35% depending on the district). In order to investigate the relationship between the deficiency of G6PD in erythrocytes and in lens, and cataractogenesis, we studied 2125 idiopathic cataractous and non-cataractous subjects, both G6PD-deficient and normal, males and females. Parameters investigated included incidence, distribution and type of cataracts, age at the moment of the first observation, geographical provenance, and G6PD activity in erythrocytes. Moreover, G6PD activity and glutathione (GSSG)-reducing activity was assessed in cataractous lenses obtained from deficient and normal individuals. G6PD deficiency was found to be significantly more frequent in males of the age-group 40-49 years (P = 0.025), while the frequency of G6PD deficiency was decisively lower in the older age-groups. In females, mainly heterozygotes, no evidence of such a relation was found. Cataractous lenses obtained from male patients with no G6PD activity in erythrocytes showed undetectable levels of G6PD activity, and lowered, but not extinguished, levels of GSSG-reducing activity. Cataractous lenses from heterozygous females showed intermediate levels of G6PD activity and GSSG-reducing activity. A preliminary study of 182 diabetic, G6PD-deficient and non-deficient subjects, failed to demonstrate that Sardinian variants of G6PD deficiency provide protection against cataract formation in diabetic patients.

Entities:  

Mesh:

Year:  1984        PMID: 6331998     DOI: 10.1007/bf00143083

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  33 in total

1.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

2.  Hereditary hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency (Mediterranean type).

Authors:  J Benbassat; D Ben-Ishay
Journal:  Isr J Med Sci       Date:  1969 Sep-Oct

3.  [Cataract and glucose-6-phosphate dehydrogenase deficiency in Sardinians].

Authors:  S Addis; G Vitali
Journal:  Boll Ocul       Date:  1970-07

4.  Glucose-6-phosphate dehydrogenase deficiency in Italy. A study of the distribution and severity of the enzymatic defect.

Authors:  E Salvidio; I Pannacciulli; A Tizianello; G Gaetani; G Paravidino
Journal:  Acta Haematol       Date:  1969       Impact factor: 2.195

5.  Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.

Authors:  D W Westring; A V Pisciotta
Journal:  Arch Intern Med       Date:  1966-10

6.  G6PD deficiency in senile cataracts.

Authors:  V Panich; S Na-Nakorn
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

7.  Heterogeneity of red cell glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in Egypt.

Authors:  P R McCurdy; K Kamel; O Selim
Journal:  J Lab Clin Med       Date:  1974-11

8.  Presenile cataract formation and decreased activity of galactosemic enzymes.

Authors:  H W Skalka; J T Prchal
Journal:  Arch Ophthalmol       Date:  1980-02

9.  Heterogeneity of "Mediterranean type" glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain and description of two new variants associated with favism.

Authors:  J L Vives Corrons; A Pujades
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

10.  Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency.

Authors:  L Corash; S Spielberg; C Bartsocas; L Boxer; R Steinherz; M Sheetz; M Egan; J Schlessleman; J D Schulman
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.